Federal Register of Legislation - Australian Government

Primary content

PB 15 of 2015 Determinations/Health as made
This instrument amends the National Health (Listed drugs on F1 or F2) Determination 2010 (No. PB 93 of 2010) in regards to three drugs that are listing on the PBS on 1 March 2015 and are required to be determined to be on either F1 or F2.
Administered by: Health
Made 24 Feb 2015
Registered 27 Feb 2015
Tabled HR 02 Mar 2015
Tabled Senate 03 Mar 2015
Date of repeal 02 Mar 2015
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

 

PB 15 of 2015

 

I, ADRIANA PLATONA, Assistant Secretary , Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated             24            February 2015

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

 

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

 

 

 

 

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 2).

         (2)   This Determination may also be cited as PB 15 of 2015.

2              Commencement

                This Determination commences on 1 March 2015.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

 

[1]     Schedule 1, after item dealing with Clostridium botulinum toxin type A toxin-haemagglutinin complex

 

Insert

 

Coal tar

 

[2]     Schedule 1, after item dealing with Peginterferon alfa-2a

 

Insert

 

Peginterferon Beta-1a

 

 

[3]     Schedule 1, after item dealing with Phenytoin

 

Insert

 

Phytomenadione